Colleagues and their associates own approx 20% of Neuren so with the buyback we effectively gained another 1 million shares in NEU by the company buying the stock ,myself and my colleagues have been patient shareholders for a very long time and we don’t intend to sell to the shorters ,we believe that once the company starts the Phelan mcdermid trial which should be in the next month that the company is well and truly in play .In our opinion the nature owner of the company going forward is not an Aussie company .
Ann: Update - Notification of buy-back - NEU, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.17 |
Change
-0.220(1.43%) |
Mkt cap ! $1.888B | |||
| Open | High | Low | Value | Volume |
| $15.45 | $15.45 | $15.03 | $6.517M | 428.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7052 | $15.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 199 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |